MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00866177 · COMPLETED

Trial details

NCT number: NCT00866177
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Melanoma Stage III Skin Melanoma Stage IV Skin Melanoma

Start date: 2009-03-01
Primary completion: 2013-09-01
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.